PMAM
EFTR

Picton Mahoney Asset Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Picton Mahoney Asset Management’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,000
Closed -$990K – 974
2021
Q2 		$990K Buy
+4,000
New +$984K 0.03% 542

Other funds holding EFTR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Picton Mahoney Asset Management's EFTR Position: Q3 2021 in Review

Picton Mahoney Asset Management sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2021, closing a stake of 4,000 shares — an estimated $990K sold.

Picton Mahoney Asset Management first reported a position in EFTR in Q2 2021 and held it in 1 quarter. The position peaked at $990K in Q2 2021. 12 funds tracked by Wall St. Rank hold EFTR as of Q3 2021.

  • Picton Mahoney Asset Management reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 4,000 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $990K.
  • Picton Mahoney Asset Management first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Picton Mahoney Asset Management's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $990K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.